Clinical trials
Phase 1/2 Central Nervous System Neoplasms trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2011 | 1 |
| 2016 | 1 |
| 2017 | 2 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 2 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 5 |
| Completed | 3 |
| Recruiting | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 2 |
| Hoffmann-La Roche | 2 |
| BBB-Therapeutics B.V. | 1 |
| BeiGene USA, Inc. | 1 |
| Blueprint Medicines Corporation | 1 |
| Centre Leon Berard | 1 |
| Institut Curie | 1 |
| Stemline Therapeutics, Inc. | 1 |
| University Hospital Heidelberg | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Central Nervous System Neoplasms | 11 |
| Neoplasms | 5 |
| Neoplasms by Site | 5 |
| Brain Neoplasms | 4 |
| Breast Neoplasms | 4 |
| Glioma | 4 |
| Lung Neoplasms | 3 |
| Thyroid Cancer, Papillary | 3 |
| Brain Diseases | 2 |
| Bronchial Neoplasms | 2 |
Trials
Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.